Biochemical and molecular studies using human autopsy brain tissue

Journal of Neurochemistry

Volumn 85, Issue 3, 2003, Pages 543-562

  Hynd, Matthew R ^a   Lewohl, Joanne M ^a   Scott, Heather L ^a   Dodd, Peter R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cryoprotection; Gene expression; Messenger RNA; Post mortem; Protein profiling

Indexed keywords

CELL DNA; COMPLEMENTARY DNA; PROTEIN; RNA;

AUTOPSY; BRAIN DISEASE; BRAIN TISSUE; CRYOPROTECTION; DATA ANALYSIS; DNA DETERMINATION; DNA MICROARRAY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ISOLATION; WESTERN BLOTTING;

EID: 0037998074     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01747.x     Document Type: Review

References (321)

1. Adolfsson R., Gottfries C. G., Roos B. E. and Winblad B. (1979a) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiat. 135, 216-223.
2. Adolfsson R., Gottfries C. G., Roos B. E. and Winblad B. (1979b) Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J. Neural Transm. 45, 81-105.
3. Alafuzoff I. and Winblad B. (1993) How to run a brain bank: potentials and pitfalls in the use of human post-mortem brain material in research. J. Neural Transm. Supplement 39, 235-243.
4. Alberghina M. and Giuffrida-Stella A. M. (1988) Age-related changes of ribonuclease activities in various regions of the rat central nervous system. J. Neurochem. 51, 21-24.
5. Albrecht U. (2002) Invited review: regulation of mammalian circadian clock genes. J. Appl. Physiol. 92, 1348-1355.
6. Anderson J. M. and Hubbard B. M. (1981) Age-related changes in Alzheimer's disease. Lancet 1, 1261.
7. Aquilonius S. M., Eckemas S. A. and Sundwall A. (1975) Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea. J. Neurol. Neurosurg. Psychiat. 38, 669-677.
8. Arranz B., Blennow K., Ekman R., Eriksson A., Mansson J. E. and Marcusson J. (1996) Brain monoaminergic and neuropeptidergic variations in human aging. J. Neural Transm. 103, 101-115.
9. Atwater J. A., Wisdom R. and Verma I. M. (1990) Regulated mRNA stability. Annu. Rev. Genet. 24, 519-541.
10. Augood S. J., Faull R. L. M., Love D. R. and Emson P. C. (1996) Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience 72, 1023-1036.
11. Augood S. J., Faull R. L. M. and Emson P. C. (1997) Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann. Neurol. 42, 215-221.
12. Bahn S., Augood S. J., Ryan M., Standaert D. G., Starkey M. and Emson P. C. (2002) Gene expression profiling in the post-mortem human brain - no cause for dismay. J. Chem. Neuroanat. 22, 79-94.
13. Balciuniene J., Emilsson L., Oreland L. and Pettersson U. J. E. (2002) Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum. Genet. 110, 1-7.
14. Bandyopadhyay R., Coutts M., Krowczynska A. M. and Brawerman G. (1990) Nuclease activity associated with mammalian mRNA in its native state: possible basis for selectivity in mRNA decay. Molec. Cell Biol. 10, 2060-2069.
15. Bar W., Kratzer A., Machler M. and Schmid W. (1988) Postmortem stability of DNA. Forensic Sci. Internat. 39, 59-70.
16. Barton A. J. L., Pearson R. C. A., Najlerahim A. and Harrison P. J. (1993) Pre- and postmortem influences on brain RNA. J. Neurochem. 61, 1-11.
17. Becker A. J., Chen J., Paus S., Normann S., Beck H., Elger C. E., Wiestler O. D. and Blumcke I. (2002) Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation. Neuroreport 13, 1327-1333.
18. Benes F. M. (1988) Post-mortem structural analyses of schizophrenic brain: study designs and the interpretation of data. Psychiat. Devel. 6, 213-226.
19. Benes F. M., Matthysse S. W., Davidson J. and Bird E. D. (1987) The spatial distribution of neurons and glia in human cortex based on the poisson distribution. Anal. Quant. Cytol. Histol. 9, 531-534.
20. Benfenati F., Cimino M., Zoli M., Grimaldi R., Zini I. and Agnati L. F. (1991) Decrease in mRNA levels but not in the density of D2 dopamine receptors in rat striatum after transient forebrain ischemia. Neurosci. Lett. 126, 6-8.
21. Bergstedt K., Hu B. R. and Wieloch T. (1993) Initiation of protein synthesis and heat-shock protein-72 expression in the rat brain following severe insulin-induced hypoglycemia. Acta Neuropathol. (Berlin) 86, 145-153.
22. Bird E. D. and Iversen L. L. (1977) Neurochemical findings in Huntington's chorea. Essays Neurochem. Neuropharmacol. 1, 177-195.
23. Bischof J. C. (2000) Quantitative measurement and prediction of biophysical response during freezing in tissues. Annu. Rev. Biomed. Eng. 2, 257-288.
24. Borderie V. M., Lopez M., Lombet A., Carvajal-Gonzalez S., Cywiner C. and Laroche L. (1998) Cryopreservation and culture of human corneal keratocytes. Invest. Ophthalmol. Vis. Sci. 39, 1511-1519.
25. Bowen D. M., Smith C. B., White P. and Davison A. N. (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99, 459-496.
26. Brawerman G. (1990) Mechanisms of mRNA decay. Trends Biotechnol. 8, 171-174.
27. Brown R., Colter N., Corsellis J. A. N., Crow T. J., Frith C. D., Jagoe R., Johnstone E. C. and Marsh L. (1986) Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch. General Psychiat. 43, 36-42.
28. Bucht G., Adolfsson R., Gottfries C. G., Roos B. E. and Winblad B. (1981) Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation. J. Neural Transm. 51, 185-203.
29. Burke W. J., O'Malley K. L., Chung H. D., Harmon S. K., Miller J. P. and Berg L. (1991) Effect of pre- and postmortem variables on specific mRNA levels in human brain. Molec. Brain Res. 11, 37-41.
30. Butterworth J. (1986) Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus. J. Neurochem. 47, 583-587.
31. Butterworth J., Yates C. M. and Simpson J. (1983) Phosphate-activated glutaminase in relation to Huntington's disease and agonal state. J. Neurochem. 41, 440-447.
32. Cai R. S., Xue D. L. and Jiang X. H. (1993) Cryopreservation and culture of the human fetal brain tissues. J. Tongji Med. University 13, 138-142.
33. Carlsson A., Svennerholm L. and Winblad B. (1980) Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiat. Scand. 280, 75-85.
34. Castensson A., Emilsson L., Preece P. and Jazin E. E. (2000) High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res. 10, 1219-1229.
35. Castensson A., Emilsson L., Preece P. and Jazin E. E. (2002) High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res. 10, 1219-1229.
36. Cerf M. E. and Raidoo D. M. (2000) Immunolocalization of plasma kallikrein in human brain. Metab. Brain Dis. 15, 315-323.
37. Cervera P., Tirard M., Barron S., Allard J., Trottier S., Lacombe J., Daumas-Duport C. and Sokoloff P. (2002) Immunohistological localization of the myelinating cell-specific receptor LP (A1). Glia 38, 126-136.
38. Cheon M. S., Fountoulakis M., Dierssen M., Ferreres J. C. and Lubec G. (2001) Expression profiles of proteins in fetal brain with Down syndrome. J. Neural Transm. Supplement 311-319:.
39. Cina S. J. (1994) Flow cytometric evaluation of DNA degradation: a predictor of postmortem interval? Am. J. Forensic Med. Pathol. 15, 300-302.
40. Clark A. W., Krekoski C. A., Parhad I. M., Liston D., Julien J. P. and Hoar D. I. (1989a) Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann. Neurol. 25, 331-339.
41. Clark A. W., Krekoski C. A., Parhad I. M., Liston D., Julien J. P. and Hoar D. I. (1989b) Altered expression of neuronal messenger RNA in Alzheimer cortex. Prog. Clin. Biol. Res. 317, 511-515.
42. Clark A. W. and Parhad I. M. (1989) Expression of neuronal mRNAs in Alzheimer type degeneration of the nervous system. Can. J. Neurol. Sci. 16, 477-482.
43. Cooper P. E., Rahman Q., Phillips T. and Tu J. (1988) Postmortem stability of somatostatin in brain tissue. Neurochem. Res. 13, 513-515.
44. Coriell L. L. (1979) Cell Culture. In: Methods in Enzymology, Vol. 58 (Jakoby, W. B. and Patson, I. R., eds), pp. 29-33. Academic Press, New York.
45. Crow T. J., Cross A. J., Johnstone E. C., Longden A., Owen F. and Ridley R. M. (1980) Time course of the antipsychotic effect in schizophrenia and some changes in postmortem brain and their relation to neuroleptic medication. Adv. Biochem. Psychopharmacol. 24, 495-503.
46. Cummings T. J., Strum J. C., Yoon L. W., Szymanski M. H. and Hulette C. M. (2001) Recovery and expression of messenger RNA from postmortem human brain tissue. Mod. Pathol. 14, 1157-1161.
47. 3H]nipecotic acid binding to γ-aminobutyric acid uptake sites in postmortem human brain. J. Neurochem. 55, 165-168.
48. Dai J., Swaab D. F., van der Vliet J. and Buijs R. M. (1998) Postmortem tracing reveals the organization of hypothalamic projections of the suprachiasmatic nucleus in the human brain. J. Comp. Neurol. 400, 87-102.
49. Dale A. M., Fischl B. and Sereno M. I. (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179-194.
50. Danon Y. L. and Kaminsky E. (1985) Dimethyl sulfoxide-induced differentiation does not alter tumorigenicity of neuroblastoma cells. J. Neurooncol. 3, 43-51.
51. Daval J. L., Nakajima T., Gleiter C. H., Post R. M. and Marangos P. J. (1989) Mouse brain c-fos mRNA distribution following a single electroconvulsive shock. J. Neurochem. 52, 1954-1957.
52. Davidsson P., Paulson L., Hesse C., Blennow K. and Nilsson C. L. (2001) Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics 1, 444-452.
53. Dawbarn D., Hunt S. P. and Emson P. C. (1984) Neuropeptide Y: regional distribution chromatographic characterization and immunohistochemical demonstration in post-mortem human brain. Brain Res. 296, 168-173.
54. De La Concha A., McKie J., Hodgkinson S., Mankoo B. S. and Gurling H. M. D. (1991) Stereospecific effect of flupenthixol on neuroreceptor gene expression. Molec. Brain Res. 10, 123-127.
55. De Lisi L. E. (1999) Structural brain changes in schizophrenia. Arch. General Psychiat. 56, 195-196.
56. Di Nunno N. R., Costantinides F., Bernasconi P., Bottin C. and Melato M. (1998) Is flow cytometric evaluation of DNA degradation a reliable method to investigate the early postmortem period? Am. J. Forensic Med. Pathol. 19, 50-53.
57. Dodd P. R. and Lewohl J. M. (1998) Cell death mediated by amino acid transmitter receptors in human alcoholic brain damage: conflicts in the evidence. Ann. NY Acad. Sci. 844, 50-58.
58. Dodd P. R., Hardy J. A., Bradford H. F., Bennett G. W., Edwardson J. A. and Harding B. N. (1979) Metabolic and secretory processes in nerve-endings isolated from post-mortem brain. Neurosci. Lett. 11, 87-92.
59. Dodd P. R., Hardy J. A., Baig E. B., Kidd A. M., Bird E. D., Watson W. E. J. and Johnston G. A. R. (1986) Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain. Neurochem. Pathol. 4, 177-198.
60. Dodd P. R., Hambley J. W., Cowburn R. F. and Hardy J. A. (1988) A comparison of methodologies for the study of functional transmitter neurochemistry in human brain. J. Neurochem. 50, 1333-1345.
61. Draper J. S., Pigott C., Thomson J. A. and Andrews P. W. (2002) Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200, 249-258.
62. Du L., Faludi G., Palkovits M., Sotonyi P., Bakish D. and Hrdina P. D. (2002) High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 13, 1195-1198.
63. Dunah A. W., Wang Y., Yasuda R. P., Kameyama K., Huganir R. L., Wolfe B. B. and Standaert D. G. (2002) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Molec. Pharmacol. 57, 342-352.
64. Dunlap J. C. (1996) Genetics and molecular analysis of circadian rhythms. Annu. Rev. Genet. 30, 579-601.
65. Eastwood S. L. and Harrison P. J. (1999) Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections. Neuroscience 93, 99-106.
66. Erkut Z. A., Pool C. and Swaab D. F. (1998) Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J. Clin. Endocrinol. Metab. 83, 2066-2073.
67. Erkut Z. A., Gabreels B. A., Eikelenboom J., van Leeuwen F. W. and Swaab D. F. (2002) Glucocorticoid treatment is associated with decreased expression of processed AVP but not of proAVP, neurophysin or oxytocin in the human hypothalamus: are PC1 and PC2 involved? Neuroendocrinol. Lett. 23, 33-44.
68. Eroglu A., Russo M. J., Bieganski R., Fowler A., Cheley S., Bayley H. and Toner M. (2000) Intracellular trehalose improves the survival of cryopreserved mammalian cells. Nature Biotechnol. 18, 163-167.
69. Escriba P. V., Sastre M. and Garcia-Sevilla J. A. (1994) Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts. Arch. General Psychiat. 51, 494-501.
70. Evers P., Uylings H. B. and Suurmeijer A. J. (1998) Antigen retrieval in formaldehyde-fixed human brain tissue. Methods 15, 133-140.
71. Fairbairn D. W., Rowe K. C. and O'Neill K. L. (1994) Video enhanced laser scanning microscopic analysis of DNA comet formation. Cell Biol. Internat. 18, 195-200.
72. Fernandez-Guasti A., Kruijver F. P., Fodor M. and Swaab D. F. (2000) Sex differences in the distribution of androgen receptors in the human hypothalamus. J. Comp. Neurol. 425, 422-435.
73. Ferrer I., Fabregues I., Pineda M., Gracia I. and Ribalta T. (1984) A Golgi study of cerebellar atrophy in human chronic alcoholism. Neuropathol. Appl. Neurobiol. 10, 245-253.
74. Fields A., Li P. P., Kish S. J. and Warsh J. J. (1999) Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J. Neurochem. 73, 1704-1710.
75. Fiorilli A., Venerando B., Siniscalco C., Monti E., Bresciani R., Caimi L., Preti A. and Tettamanti G. (1989) Occurrence in brain lysosomes of a sialidase active on ganglioside. J. Neurochem. 53, 672-680.
76. Fischl B., Sereno M. I. and Dale A. M. (1999) Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9, 195-207.
77. Fitzmaurice P. S., Bamsey C. L., Ang L., Guttman M., Rajput A. H., Furukawa Y. and Kish S. J. (2002) Brain aconitase activity is not decreased in progressive supranuclear palsy. Neurology 59, 137-138.
78. Foley P. F. and Dodd P. R. (1996) Dopamine D2 receptor (D2R) genotype differentiates intravenous drug abusers from alcoholics and non-abusers. Ann. NY Acad. Sci. 801, 409-414.
79. Francis P. T., Bowen D. M., Lowe S. L., Neary D., Mann D. M. A. and Snowdon J. S. (1987) Somatostatin content and release measured in cerebral biopsies from demented patients. J. Neurol. Sci. 78, 1-16.
80. Franzoni L. and Garcia Argiz C. A. (1978) Rat brain ribonucleases. Acta Physiol. Lat. Am. 28, 185-192.
81. Furuki T. (2000) Effect of stereochemistry on the anti-freeze characteristics of carbohydrates. A thermal study of aqueous monosaccharides at subzero temperatures. Carbohydr. Res. 323, 185-191.
82. Gilbert J. M., Brown B. A., Strocchi P., Bird E. D. and Marotta C. A. (1981) The preparation of biologically active messenger RNA from human postmortem brain tissue. J. Neurochem. 36, 976-984.
83. Glasel J. A. (1995) Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Biotechniques 18, 62-63.
84. Gleitz J., Beile A., Wilffert B. and Tegtmeier F. (1993) Cryopreservation of freshly isolated synaptosomes prepared from the cerebral cortex of rats. J. Neurosci. Meth. 47, 191-197.
85. Glick S. D., Merski C., Steindorf S., Wang S., Keller R. W. and Carlson J. N. (1992) Neurochemical predisposition to self-administer morphine in rats. Brain Res. 578, 215-220.
86. Godfrey T. E., Kim S. H., Chavira M., Ruff D. W., Warren R. S., Gray J. W. and Jensen R. H. (2000) Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction. J. Molec. Diagn. 2, 84-91.
87. Goldstine J., Seligson D. B., Beizai P., Miyata H. and Vinters H. V. (2002) Tissue microarrays in the study of non-neoplastic disease of the nervous system. J. Neuropathol. Exper. Neurol. 61, 653-662.
88. Goldstone A. P., Unmehopa U. A., Bloom S. R. and Swaab D. F. (2002) Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J. Clin. Endocrinol. Metab. 87, 927-937.
89. Goncharuk V. D., van Heerikhuize J., Swaab D. F. and Buijs R. M. (2002) Paraventricular nucleus of the human hypothalamus in primary hypertension: activation of corticotropin-releasing hormone neurons. J. Comp. Neurol. 443, 321-331.
90. Grachev I. D. and Apkarian A. Y. (2000a) Chemical heterogeneity of the living human brain: a proton MR spectroscopy study on the effects of sex, age, and brain region. Neuroimage 11, 554-563.
91. 1H-MRS study on the effects of sex, age, and brain region. Hum. Brain Mapp. 11, 261-272.
92. Guan M., Su B. and Lu Y. (2002) Quantitative reverse transcription-PCR measurement of tissue factor mRNA in glioma. Molec. Biotechnol. 20, 123-129.
93. Guhaniyogi J. and Brewer G. (2002) Regulation of mRNA stability in mammalian cells. Gene 265, 11-23.
94. Guidotti A., Auta J., Davis J. M., Di Giorgi-Gerevini V., Dwivedi Y., Grayson D. R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E. and Di Giorgi-Gerevini V. (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. General Psychiat. 57, 1061-1069.
95. Guillemette J. G., Wong L., McLachlan D. R. and Lewis P. N. (1986) Characterization of messenger RNA from the cerebral cortex of control and Alzheimer-afflicted brain. J. Neurochem. 47, 987-997.
96. Haan E. A. and Bowen D. M. (1981) Protection of neocortical tissue prisms from freeze-thaw injury by dimethyl sulphoxide. J. Neurochem. 37, 243-246.
97. Haberland N. and Hetey L. (1987) Studies in postmortem dopamine uptake. I. Kinetic characterization of the synaptosomal dopamine uptake in rat and human brain after postmortem storage and cryopreservation. Comparison with noradrenaline and serotonin uptake. J Neural Transm. 68, 289-301.
98. Hardy J. A. and Dodd P. R. (1983) Metabolic and functional studies on post-mortem human brain. Neurochem. Internat. 5, 253-266.
99. Hardy J. A. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
100. Hardy J. A., Dodd P. R., Oakley A. E., Perry R. H., Edwardson J. A. and Kidd A. M. (1983) Metabolically active synaptosomes can be prepared from frozen rat and human brain. J. Neurochem. 40, 608-614.
101. Hardy J. A., Bateman D. E., Kidd A. M., Edwardson J. A., Singh G. B. and Dodd P. R. (1984) Amino acid transport by synaptosomes isolated from post mortem human brain. J. Neural Transm. 60, 57-62.
102. Hardy J. A., Wester P., Winblad B., Gezelius C., Bring G. and Eriksson A. (1985) The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J. Neural Transm. 61, 253-264.
103. Harper C. G. and Kril J. J. (1985) Brain atrophy in chronic alcoholic patients: a quantitative pathological study. J. Neurol. Neurosurg. Psychiat. 48, 211-217.
104. Harper C. G. and Kril J. J. (1986) Pathological changes in alcoholic brain shrinkage. Med. J. Aust. 144, 3-4.
105. Harper C. G., Kril J. J. and Holloway R. L. (1985) Brain shrinkage in chronic alcoholics: a pathological study. Brit. Medical J. Clin. Res. Ed. 290, 501-504.
106. Harrington C. R., Mukaetova-Ladinska E. B., Hills R., Edwards P. C., Montejo de Garcini E., Novak M. and Wischik C. M. (1991) Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 5842-5846.
107. Harrison P. J., Procter A. W., Barton A. J. L., Lowe S. L., Najlerahim A., Bertolucci P. H., Bowen D. M. and Pearson R. C. A. (1991) Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Molec. Brain Res. 9, 161-164.
108. Harrison P. J., Procter A. W., Exworthy T., Roberts G. W., Najlerahim A., Barton A. J. L. and Pearson R. C. A. (1993) Heat shock protein (hsx70) mRNA expression in human brain: effects of neurodegenerative disease and agonal state. Neuropathol. Appl. Neurobiol. 19, 10-21.
109. Harrison P. J., Heath P. R., Eastwood S. L., Burnet P. W., McDonald B. L. and Pearson R. C. A. (1995) The relative importance of pre-mortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200, 151-154.
110. A receptor subunits in vivo. Proceedings of the Aust. Neurosci. Soc. 11, 175.
111. Herzog E. D. and Schwartz W. J. (2002) A neural clockwork for encoding circadian time. J. Appl. Physiol. 92, 401-408.
112. Hippe-Sanwald S. (1993) Impact of freeze substitution on biological electron microscopy. Microsc. Res. Techn 24, 400-422.
113. Hoff-Olsen P., Jacobsen S., Mevag B. and Olaisen B. (2002) Microsatellite stability in human post-mortem tissues. Forensic Sci. Internat. 119, 273-278.
114. Hofman M. A. and Swaab D. F. (1994) Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 651, 134-142.
115. Hofman M. A. and Swaab D. F. (1995) Influence of aging on the seasonal rhythm of the vasopressin-expressing neurons in the human suprachiasmatic nucleus. Neurobiol. Aging 16, 965-971.
116. Hommer D., Momenan R., Kaiser E. and Rawlings R. (2001) Evidence for a gender-related effect of alcoholism on brain Volumes. Am. J. Psychiat. 158, 198-204.
117. Huckenbeck W. and Bonte W. (1992) DNA fingerprinting of freeze-dried tissues. Internat. J. Legal Med. 105, 39-41.
118. Hudson L., Liu J., Nath A., Jones M., Raghavan R., Narayan O., Male D. and Everall I. (2000) Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirol. 6, 145-155.
119. Hulshoff-Pol H. E., Schnack H. G., Bertens M. G., van Haren N. E., van der Tweel I., Staal W. G., Baare W. F. and Kahn R. S. (2002) Volume changes in gray matter in patients with schizophrenia. Am. J. Psychiat. 159, 244-250.
120. Husi H. and Grant S. G. (2001) Proteomics of the nervous system. Trends Neurosci. 24, 259-266.
121. Hutsler J. J., Loftus W. C. and Gazzaniga M. S. (1998) Individual variation of cortical surface area asymmetries. Cereb. Cortex 8, 11-17.
122. NMDA receptor NR1 subunit mRNA expression in Alzheimer's disease. J. Neurochem. 78, 175-182.
123. Ilaria R., Wines D., Pardue S., Jamison S., Ojeda S. R., Snider J. and Morrison M. R. (1985) A rapid microprocedure for isolating RNA from multiple samples of human and rat brain. J. Neurosci. Meth. 15, 165-174.
124. Irazusta J., Larrinaga G., Gonzalez-Maeso J., Gil J., Meana J. J. and Casis L. (2002) Distribution of prolyl endopeptidase activities in rat and human brain. Neurochem. Internat. 40, 337-345.
125. Ishiguro H. and Koike K. (1998) Three-dimensional behavior of ice crystals and biological cells during freezing of cell suspensions. Ann. NY Acad. Sci. 858, 235-244.
126. Ishunina T. A. and Swaab D. F. (1999) Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus: size changes in relation to age and sex. J. Clin. Endocrinol. Metab. 84, 4637-4644.
127. Ishunina T. A., Salehi A., Hofman M. A. and Swaab D. F. (1999) Activity of vasopressinergic neurones of the human supraoptic nucleus is age- and sex-dependent. J. Neuroendocrinol. 11, 251-258.
128. Iwangoff P., Enz A., Armbruster R., Emmenegger H., Pataki A. and Sandoz P. (1980) The influence of aging, post-mortem delay until isolation of the tissue and duration of agony on some glycolytic enzymes in human autoptic brain tissue. Aktuelle Gerontol. 10, 203.
129. Jiang S. and Nail S. L. (1998) Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur. J. Pharm. Biopharm. 45, 249-257.
130. Johnson L. A. and Ferris J. A. (2002) Analysis of postmortem DNA degradation by single-cell gel electrophoresis. Forensic Sci. Internat. 126, 43-47.
131. Johnson S. A., Morgan D. G. and Finch C. E. (1986) Extensive post-mortem stability of RNA from rat and human brain. J. Neurosci. Res. 16, 267-280.
132. Johnson S. A., Pasinetti G. M., May P. C., Ponte P. A., Cordell B. and Finch C. E. (1988) Selective reduction of mRNA for the β-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exper. Neurol. 102, 264-268.
133. Johnston N. L., Cervenak J., Shore A. D., Torrey E. F., Yolken R. H. and Cerevnak J. (1997) Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. J. Neurosci. Meth. 77, 83-92.
134. Kammoun S., Gold G., Bouras C., Giannakopoulos P., McGee W., Herrmann F. and Michel J. P. (2000) Immediate causes of death of demented and non-demented elderly. Acta Neurol. Scand. 176, 96-99.
135. Karlsson J. O. and Toner M. (1996) Long-term storage of tissues by cryopreservation: critical issues. Biomaterials 17, 243-256.
136. Keene J., Hope T., Fairburn C. G. and Jacoby R. (2001) Death and Dementia. Internat. J. Geriat. Psychiat. 16, 969-974.
137. Kingsbury A. E., Foster O. J., Nisbet A. P., Cairns N., Bray L., Eve D. J., Lees A. J. and Marsden C. D. (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Molec. Brain Res. 28, 311-318.
138. Kingsbury A. E., Mardsen C. D. and Foster O. J. (1998) DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov. Disord. 13, 877-884.
139. Kinzinger G. and Holtz J. (1992) DNA of cadaver organs: comparison of two methods of extraction. Beitr. Gerichtl. Med. 50, 283-287.
140. Kish S. J., Kalasinsky K. S., Furukawa Y., Guttman M., Ang L., Li L., Adams V., Reiber G., Anthony R. A., Anderson W., Smialek J. and Di Stefano L. (1999) Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin. Molec. Psychiat. 4, 26-32.
141. Kitagaki H., Mori E., Yamaji S., Ishii K., Hirono N., Kobashi S. and Hata Y. (1998) Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Radiology 208, 431-439.
142. Klimek V., Zhu M. Y., Dilley G., Konick L., Overholser J. C., Meltzer H. Y., May W. L., Stockmeier C. A. and Ordway G. A. (2001) Effects of long-term cigarette smoking on the human locus cœruleus. Arch. General Psychiat. 58, 821-827.
143. Kloosterman A. D., Budowle B. and Daselaar P. (1993) PCR-amplification and detection of the human D1S80 VNTR locus. Amplification conditions, population genetics and application in forensic analysis. Internat. J. Legal Med. 105, 257-264.
144. Kobayashi M., Sakai E., Furuta Y. and Takamatsu K. (1998) Isolation of two human cDNAs, HLP3 and HLP4, homologous to the neuron-specific calcium-binding protein genes. DNA Seq. 9, 171-176.
145. Koenig H. (1964) Neuronal lipofuscin in disease. Its relation to lysosomes. Trans. Am. Neurol. Assoc. 89, 212-213.
146. Konradi C., Kornhuber J., Sofic E., Heckers S., Riederer P. and Beckmann H. (1992) Variations of monoamines and their metabolites in the human brain putamen. Brain Res. 579, 285-290.
147. Kosel S., Grasbon-Frodl E. M., Arima K., Chimelli L., Hahn M., Hashizume Y., Hulette C., Ikeda K., Jacobsen P. F., Jones M., Kobayashi M., Love S., Mizutani T., Rosemberg S., Sasaki A., Smith T. W., Takahashi H., Vortmeyer A. O. and Graeber M. B. (2001) Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continents. Neurogenetics 3, 163-170.
148. Kosunen O., Soininen H., Paljarvi L., Heinonen O., Talasniemi S. and Riekkinen P. J. (1996) Diagnostic accuracy of Alzheimer's disease: a neuropathological study. Acta Neuropathol. (Berlin) 91, 185-193.
149. Kovacs Z., Dobolyi A., Szikra T., Palkovits M. and Juhasz G. (1998) Uneven regional distribution of nucleotide metabolism in human brain. Neurobiology 6, 315-321.
150. Kozlovsky N., Belmaker R. H. and Agam G. (2001) Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr. Res. 52, 101-105.
151. Kril J. J. and Butterworth R. F. (1997) Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. Hepatology 26, 837-841.
152. Krowczynska A. M., Yenofsky R. and Brawerman G. (1985) Regulation of messenger RNA stability in mouse erythroleukemia cells. J. Molec. Biol. 181, 231-239.
153. Kruijver F. P., Fernandez-Guasti A., Fodor M., Kraan E. M. and Swaab D. F. (2001) Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J. Clin. Endocrinol. Metab. 86, 818-827.
154. Lahiri D. K. and Ge Y. (2000) Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue. Brain Res. Prot. 5, 257-265.
155. Langstrom N. S., Anderson J. P., Lindroos H. G., Winblad B. and Wallace W. C. (1989) Alzheimer's disease-associated reduction of polysomal mRNA translation. Molec. Brain Res. 5, 259-269.
156. Lauriello J., Hoff A., Wieneke M. H., Blankfeld H., Faustman W. O., Rosenbloom M., De Ment S., Sullivan E. V., Lim K. O. and Pfefferbaum A. (1997) Similar extent of brain dysmorphology in severely ill women and men with schizophrenia. Am. J. Psychiat. 154, 819-825.
157. Lausson S., Segond N., Milhaud G. and Staub J. F. (1989) Circadian rhythms of calcitonin gene expression in the rat. J. Endocrinol. 122, 527-534.
158. Leal-Klevezas D. S., Martinez-Vazquez I. O., Cuevas-Hernandez B. and Martinez-Soriano J. P. (2000) Antifreeze solution improves DNA recovery by preserving the integrity of pathogen-infected blood and other tissues. Clin. Diagn. Laboratory Immunol. 7, 945-946.
159. Lee D. H., Chung M. J., Lee J. U., Kang D. G. and Paek Y. W. (2002) Changes of glucose transporters in the cerebral adaptation to hypoglycemia. Diabetes Res. Clin. Pract. 47, 15-23.
160. Leonard S. S., Logel J., Luthman D., Casanova M., Kirch D., Freedman R. (1991) Parameters affecting the use of human post-mortem brain for molecular biological studies. Soc. Neurosci. Abstract. 17, 379.
161. Leonard S. S., Logel J., Luthman D., Casanova M., Kirch D. and Freedman R. (1993) Biological stability of mRNA isolated from human postmortem brain collections. Biol. Psychiat. 33, 456-466.
162. A receptor in human alcoholic brain. Brain Res. 751, 102-112.
163. A receptor in brain from human cirrhotic and non-cirrhotic alcoholics. Eur. J. Pharmacol. 326, 265-272.
164. A receptor α subunit proteins in human chronic alcoholics. J. Neurochem. 78, 424-434.
165. Li S., Mallory M., Alford M., Tanaka S. and Masliah E. (1997) Glutamate transporter alterations in Alzheimer's disease are possibly associated with abnormal APP expression. J. Neuropathol. Exper. Neurol. 56, 901-911.
166. Lin T. N., Te J., Huang H. C., Chi S. I. and Hsu C. Y. (1997) Prolongation and enhancement of postischemic c-fos expression after fasting. Stroke 28, 412-418.
167. Lockhart D. J. and Barlow C. (2001) Expressing what's on your mind: DNA arrays and the brain. Nature Rev. Neurosci. 2, 63-68.
168. Lovell M. A., Xie C. and Markesbery W. R. (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566.
169. Loven D. P., James J. F., Biggs L. and Little K. Y. (1996) Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients. Biol. Psychiat. 40, 230-232.
170. Lowe S. L., Francis P. T., Procter A. W., Palmer A. M., Davison A. N. and Bowen D. M. (1988) γ-Aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. Brain 111, 785-799.
171. Low-Zeddies S. S. and Takahashi J. S. (2001) Chimera analysis of the Clock mutation in mice shows that complex cellular integration determines circadian behavior. Cell 105, 25-42.
172. Ludes B., Pfitzinger H. and Mangin P. (1993) DNA fingerprinting from tissues after variable postmortem periods. J. Forensic Sci. 38, 686-690.
173. Lukiw W. J., Wong L. and McLachlan D. (1990) Cytoskeletal messenger RNA stability in human neocortex: studies in normal aging and in Alzheimer's disease. Internat. J. Neurosci. 55, 81-88.
174. Maker H. S., Weiss C., Weissbarth S., Silides D. J. and Whetsell W. O. J. (1981) Regional activities of metabolic enzymes and glutamate decarboxylase in human brain. Ann. Neurol. 10, 377-383.
175. Mangin P. D. and Ludes B. P. (1991) A forensic application of DNA typing. Paternity determination in a putrefied fetus. Am. J. Forensic Med. Pathol. 12, 161-163.
176. Mann D. M. A., Barton C. M. and Davies J. S. (1978) Post-mortem changes in human central nervous tissue and the effects on quantitation of nucleic acids and enzymes. Histochem. J. 10, 127-135.
177. Marotta C. A., Brown B. A., Strocchi P., Bird E. D. and Gilbert J. M. (1981) In vitro synthesis of human brain proteins including tubulin and actin by purified postmortem polysomes. J. Neurochem. 36, 966-975.
178. Maschhoff K., White C. L., 3rd, Jennings L. W. and Morrison-Bogorad M. R. (1989) Ribonuclease activities and distribution in Alzheimer's and control brains. J. Neurochem. 52, 1071-1078.
179. Matthysse S. (1980) Nucleus accumbens and schizophrenia. In: The Neurobiology of the Nucleus Accumbens (Chronister, R. B. and De France, J. F., eds), pp. 351-357. Haer Institute, Maine.
180. Maudgil D. D., Free S. L., Sisodiya S. M., Lemieux L., Woermann F. G., Fish D. R. and Shorvon S. D. (1998) Identifying homologous anatomical landmarks on reconstructed magnetic resonance images of the human cerebral cortical surface. J. Anat. 193, 559-571.
181. Mayfield R. D., Lewohl J. M., Dodd P. R., Herlihy A., Liu J. and Harris R. A. (2002) Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J. Neurochem. 81, 802-813.
182. McGeer P. L., McGeer E. G. and Suzuki J. (1977) Aging and extrapyramidal function. Arch. Neurol. 34, 33-35.
183. McGeer P. L., McGeer E. G. and Wada J. A. (1971) Glutamic acid decarboxylase in Parkinson's disease and epilepsy. Neurology 21, 1000-1007.
184. McLeman E. R., Warsh J. J., Ang L., Li P. P., Kalasinsky K. S., Ross B. M., Tong J., Schmunk G., Adams V. and Kish S. J. (2000) The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. J. Neurochem. 74, 2120-2126.
185. Meier-Ruge W., Hunziker O. and Iwangoff P. (1991) Senile dementia: a threshold phenomenon of normal aging? A contribution to the functional reserve hypothesis of the brain. Ann. NY Acad. Sci. 621, 104-118.
186. Merched A., Serot J. M., Visvikis S., Aguillon D., Faure G. and Siest G. (1998) Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett. 425, 225-228.
187. Mikami H., Terazawa K., Takatori T., Tokudome S., Tsukamoto T. and Haga K. (1994) Estimation of time of death by quantification of melatonin in corpses. Internat. J. Legal Med. 107, 42-51.
188. Mitchell P. and Tollervey D. (2002) Musing on the structural organization of the exosome complex. Nature Struct. Biol. 7, 843-846.
189. Mori K., Kanemura Y., Fujikawa H., Nakano A., Ikemoto H., Ozaki I., Matsumoto T., Tamura K., Yokota M. and Arita N. (2002) Brain-specific angiogenesis inhibitor 1 (BAI1) is expressed in human cerebral neuronal cells. Neurosci. Res. 43, 69-74.
190. Morrison M. R. and Griffin W. S. (1981) The isolation and in vitro translation of undegraded messenger RNAs from human post-mortem brain. Anal. Biochem. 113, 318-324.
191. Morrison L. D. and Kish S. J. (1995) Brain polyamine levels are altered in Alzheimer's disease. Neurosci. Lett. 197, 5-8.
192. Morrison L. D., Bergeron C. and Kish S. J. (1993) Brain S-adeno-sylmethionine decarboxylase activity is increased in Alzheimer's disease. Neurosci. Lett. 154, 141-144.
193. Morrison-Bogorad M., Zimmerman A. L. and Pardue S. (1995) Heat-shock 70 messenger RNA levels in human brain: correlation with agonal fever. J. Neurochem. 64, 235-246.
194. Mullaart E., Boerrigter M. E., Ravid R., Swaab D. F. and Vijg J. (1990) Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol. Aging 11, 169-173.
195. Najlerahim A. and Bowen D. M. (1988) Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type. Acta Neuropathol. (Berlin) 75, 509-512.
196. Nakajima T., Daval J. L., Gleiter C. H., Deckert J., Post R. M. and Marangos P. J. (1989) C-fos mRNA expression following electrical-induced seizure and acute nociceptive stress in mouse brain. Epilepsy Res. 4, 156-159.
197. Narr K. L., Thompson P. M., Sharma T., Moussai J., Blanton R., Anvar B., Edris A., Krupp R., Rayman J., Khaledy M. and Toga A. W. (2001a) Three-dimensional mapping of temporo-limbic regions and the lateral ventricles in schizophrenia: gender effects. Biol. Psychiat. 50, 84-97.
198. Narr K. L., Thompson P. M., Sharma T., Moussai J., Zoumalan C., Rayman J. and Toga A. (2001b) Three-dimensional mapping of gyral shape and cortical surface asymmetries in schizophrenia: gender effects. Am. J. Psychiat. 158, 244-255.
199. Nasrallah H. A. (1995) Brain and CSF Volume differences in schizophrenic subtypes. Am. J. Psychiat. 152, 817.
200. Nichols N. R., Day J. R., Laping N. J., Johnson S. A. and Finch C. E. (1993) GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 14, 421-429.
201. Nichols N. R., Masters J. N. and Finch C. E. (1990) Changes in gene expression in hippocampus in response to glucocorticoids and stress. Brain Res. Bull. 24, 659-662.
202. Nishimori T., Buzzi M. G., Moskowitz M. A. and Uhl G. R. (1989) Preproenkephalin mRNA expression in nucleus caudalis neurons is enhanced by trigeminal stimulation. Molec. Brain Res. 6, 203-210.
203. Nochlin D., Mackenzie A. P., Bryant E. M., Norwood T. H. and Sumi S. M. (1993) A simple method of rapid freezing adequately preserves brain tissue for immunocytochemistry, light and electron microscopic examination. Acta Neuropathol. (Berlin) 86, 645-650.
204. Nopoulos P., Flaum M., O'Leary D. and Andreasen N. C. (2000) Sexual dimorphism in the human brain: evaluation of tissue volume, tissue composition and surface anatomy using magnetic resonance imaging. Psychiat. Res. 98, 1-13.
205. Nurnberg P., Roewer L., Neitzel H., Sperling K., Popperl A., Hundrieser J., Poche H., Epplen C., Zischler H. and Epplen J. (1989) DNA fingerprinting with the oligonucleotide probe (CAC) 5/ (GTG) 5: somatic stability and germline mutations. Hum. Genet. 84, 75-78.
206. Octave J.-N., de Sauvage F., Macq A.-F. and Maloteaux J.-M. (1988) Cloning of the cDNA from normal brain and brain of patients with Alzheimer's disease in the expression vector λGT 11. Prog. Neuropsychopharmacol. Biol. Psychiat. 12, 813-820.
207. Oehmichen M. (1980) Enzyme alterations in brain tissue during the early postmortal interval with reference to the histomorphology: review of the literature. Z. Rechtsmed. 85, 81-95.
208. Oxenkrug G. F., Anderson G. F., Dragovic L., Blaivas M. and Riederer P. (1990) Circadian rhythms of human pineal melatonin, related indoles, and β adrenoreceptors: post-mortem evaluation. J. Pineal. Res. 9, 1-11.
209. Ozaita A., Escriba P. V., Ventayol P., Murga C., Mayor F. J. and Garcia-Sevilla J. A. (1998) Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. J. Neurochem. 70, 1249-1257.
210. Palmer A. M., Wilcock G. K., Esiri M. M., Francis P. T. and Bowen D. M. (1987) Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res. 401, 231-238.
211. Palmer A. M., Lowe S. L., Francis P. T. and Bowen D. M. (1988a) Are post-mortem biochemical studies of human brain worthwhile? Biochem. Soc. Trans. 16, 472-475.
212. Palmer A. M., Stratmann G. C., Procter A. W. and Bowen D. M. (1988b) Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann. Neurol. 23, 616-620.
213. Panda S., Antoch M. P., Miller B. H., Su A. I., Schook A. B., Straume M., Schultz P. G., Kay S. A., Takahashi J. S. and Hogenesch J. B. (2002a) Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109, 307-320.
214. Panda S., Hogenesch J. B. and Kay S. A. (2002b) Circadian rhythms from flies to human. Nature 417, 329-335.
215. Pandey G. N., Dwivedi Y., Pandey S. C., Teas S. S., Conley R. R., Roberts R. C. and Tamminga C. A. (1999) Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C β1 protein in the prefrontal cortex of teenage suicide subjects. Am. J. Psychiat. 156, 1895-1901.
216. 2A receptors in the post-mortem brains of teenage suicide victims. Am. J. Psychiat. 159, 419-429.
217. Pappas B. A., Bayley P. J., Bui B. K., Hansen L. A. and Thal L. J. (2000) Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients. Neurobiol. Aging 21, 11-17.
218. Paschen W., Djuricic B., Mies G., Schmidt-Kastner R. and Linn F. (1987) Lactate and pH in the brain: association and dissociation in different pathophysiological states. J. Neurochem. 48, 154-159.
219. Pasinetti G. M. (2001) Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J. Neurosci. Res. 65, 471-476.
220. Pegg D. E. (2002) Cryopreservation of vascular endothelial cells as isolated cells and as monolayers. Cryobiology 44, 46-53.
221. Peltz S. W., Brewer G., Bernstein P., Hart P. A. and Ross J. (1991) Regulation of mRNA turnover in eukaryotic cells. Crit. Rev. Eukaryot. Gene Expr. 1, 99-126.
222. Perez-Velazquez J. L. and Zhang L. (1994) In vitro hypoxia induces expression of the NR2C subunit of the NMDA receptor in rat cortex and hippocampus. J. Neurochem. 63, 1171-1173.
223. Perrett C. W., Marchbanks R. M. and Whatley S. A. (1988) Characterisation of messenger RNA extracted post-mortem from the brains of schizophrenic, depressed and control subjects. J. Neurol. Neurosurg. Psychiat. 51, 325-331.
224. Perry E. K., Gibson P. H., Blessed G., Perry R. H. and Tomlinson B. E. (1977) Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci. 34, 247-265.
225. Perry R. H., Irving D. and Tomlinson B. E. (1990) Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. J. Neurol. Sci. 100, 223-233.
226. Persinger M. A. (1993) Average diurnal changes in melatonin levels are associated with hourly incidence of bereavement apparitions: support for the hypothesis of temporal (limbic) lobe microseizuring. Percept. Mot. Skills 76, 444-446.
227. Petit T. L. and Le Boutillier J. C. (1990) Quantifying synaptic number and structure: effects of stain and post-mortem delay. Brain Res. 517, 269-275.
228. Pfefferbaum A., Sullivan E. V., Mathalon D. H. and Lim K. O. (1997) Frontal lobe Volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol. Clin. Exper. Res. 21, 521-529.
229. Pfefferbaum A., Rosenbloom M. J., Deshmukh A. and Sullivan E. V. (2001) Sex differences in the effects of alcohol on brain structure. Am. J. Psychiat. 158, 188-197.
230. Pittendrigh C. S. (1993) Temporal organization: reflections of a Darwinian clock-watcher. Annu. Rev. Physiol. 55, 16-54.
231. Poche H., Wrobel G., Schneider V. and Epplen J. T. (1990) Oligonucleotide fingerprinting using (GTG) 5 and (GACA) 4 probes for the differentiation of body fragments. Arch. Kriminol. 186, 37-42.
232. Procter A. W., Lowe S. L., Palmer A. M., Francis P. T, Esiri M. M., Stratmann G. C., Najlerahim A., Patel A. J., Hunt A. and Bowen D. M. (1988) Topographical distribution of neurochemical changes in Alzheimer's disease. J. Neurol. Sci. 84, 125-140.
233. Procter A. W., Doshi R., Bowen D. M. and Murphy E. (1990) Rapid autopsy brains for biochemical research: Experiences in establishing a program. Internat. J. Geriat. Psychiat. 5, 287-294.
234. Ralph M. R. and Menaker M. (1988) A mutation of the circadian system in golden hamsters. Science 241, 1225-1227.
235. Rampello L., Patti F., Condorelli D. F., Reggio A., Prato A., Canonico P. L. and Nicoletti F. (1982) Effects of some typical and atypical antidepressants on GAD activity in various brain regions. Encephale 8, 89-94.
236. Rand A., Ansari K. A. and Loch J. (1979) 2′,3′-Cyclic nucleotides 3′-phosphodiesterase activity of human white matter and time interval between death and autopsy. J. Neurochem. 32, 627-628.
237. Ravid R., van Zwieten E. J. and Swaab D. F. (1992) Brain banking and the human hypothalamus - factors to match for, pitfalls and potentials. Prog. Brain Res. 93, 83-95.
238. Rees S. (1976) A quantitative electron microscopic study of the ageing human cerebral cortex. Acta Neuropathol. (Berlin) 36, 347-362.
239. Rees S. (1977) The incidence of ultrastructural abnormalities in the cortex of two retarded human brains (Down's syndrome). Acta Neuropathol. (Berlin) 37, 65-68.
240. Regeur L. (2000) Increasing loss of brain tissue with increasing dementia: a stereological study of post-mortem brains from elderly females. Eur. J. Neurol. 7, 47-54.
241. Rehncrona S., Rosen I. and Siesjo B. K. (1980) Excessive cellular acidosis: an important mechanism of neuronal damage in the brain? Acta Physiol. Scand. 110, 435-437.
242. Reiach J. S., Li P. P., Warsh J. J., Kish S. J. and Young L. T. (1999) Reduced adenylyl cyclase immunolabeling and activity in post-mortem temporal cortex of depressed suicide victims. J. Affect. Disord. 56, 141-151.
243. Reinikainen K. J., Paljarvi L., Huuskonen M., Soininen H., Laakso M. and Riekkinen P. J. (1988) A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease. J. Neurol. Sci. 84, 101-116.
244. Relf B. L., Machaalani R. and Waters K. A. (2002) Retrieval of mRNA from paraffin-embedded human infant brain tissue for non-radioactive in situ hybridization using oligonucleotides. J. Neurosci. Meth 115, 129-136.
245. Reppert S. M. and Weaver D. R. (2002) Coordination of circadian timing in mammals. Nature 418, 935-941.
246. Resnick S. M., Goldszal A. F., Davatzikos C., Golski S., Kraut M. A., Metter E. J., Bryan R. N. and Zonderman A. B. (2000) One-year age changes in MRI brain Volumes in older adults. Cereb. Cortex 10, 464-472.
247. Rivkees S. A., Chaar M. R., Hanley D. F., Maxwell M., Reppert S. M. and Uhl G. R. (1989) Localization and regulation of vasopressin mRNA in human neurons. Synapse 3, 246-254.
248. Ross J. (1988) Messenger RNA turnover in eukaryotic cells. Molec. Biol. Med. 5, 1-14.
249. Ross B. M., Knowler J. T. and McCulloch J. (1992) On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease. J. Neurochem. 58, 1810-1819.
250. Rothman S. M. and Olney J. W. (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci. 10, 299-302.
251. Roytta M., Laaksonen H., Frey H., Riekkinen P. J. and Rinne U.K. (1980) Critical evaluation of the postmortem factors influencing neurochemical analyses of brain autopsies. Acta Neurol. Scand. 61, 88-106.
252. Rusnak M., Jelokova J., Vietor I., Sabban E. L. and Kvetnansky R. (1998) Different effects of insulin and 2-deoxy-D-glucose administration on tyrosine hydroxylase gene expression in the locus cœruleus and the adrenal medulla in rats. Brain Res. Bull. 46, 447-452.
253. Saini K. S., Summerhayes I. C. and Thomas P. (1990) Molecular events regulating messenger RNA stability in eukaryotes. Molec. Cell. Biochem. 96, 15-23.
254. Sajdel-Sulkowska E. M. and Marotta C. A. (1984) Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. Science 225, 947-949.
255. Sajdel-Sulkowska E. M., Coughlin J. F. and Marotta C. A. (1983) In vitro synthesis of polypeptides of moderately large size by poly (A)-containing messenger RNA from postmortem human brain and mouse brain. J. Neurochem. 40, 670-680.
256. Sajdel-Sulkowska E. M., Majocha R. E., Salim M., Zain S. B. and Marotta C. A. (1988) The post-mortem Alzheimer brain is a source of structurally and functionally intact astrocytic messenger RNA. J. Neurosci. Meth. 23, 173-179.
257. Salat D. H., Kaye J. A. and Janowsky J. S. (1999) Prefrontal gray and white matter Volumes in healthy aging and Alzheimer disease. Arch. Neurol. 56, 338-344.
258. Salim H., Ferre S., Dalal A., Peterfreund R. A., Fuxe K., Vincent J. D. and Lledo P. M. (2002) Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells. J. Neurochem. 74, 432-439.
259. Sastre M., Ventayol P. and Garcia-Sevilla J. A. (1996) Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts. Neuroreport 7, 509-512.
260. Schafer A. T. and Kaufmann J. D. (1999) What happens in freezing bodies? Experimental study of histological tissue change caused by freezing injuries. Forensic Sci. Internat. 102, 149-158.
261. Scheff S. W., Sparks D. L. and Price D. A. (1996) Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia 7, 226-232.
262. Schindler M., Harrington K. A., Humphrey P. P. and Emson P. C. (1995) Cellular localisation and co-expression of somatostatin receptor messenger RNAs in the human brain. Molec. Brain Res. 34, 321-326.
263. Schonberger S. J., Edgar P. F., Kydd R., Faull R. L. and Cooper G. J. (2001) Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 1, 1519-1528.
264. Schramm M., Falkai P., Tepest R., Schneider-Axmann T., Przkora R., Waha A., Pietsch T., Bonte W. and Bayer T. A. (1999) Stability of RNA transcripts in post-mortem psychiatric brains. J. Neural Transm. 106, 329-335.
265. Schwarcz R. (1981) Effects of tissue storage and freezing on brain glutamate uptake. Life Sci. 28, 1147-1154.
266. Schwarcz R. and Whetsell W. O. J. (1982) Post-mortem high affinity glutamate uptake in human brain. Neuroscience 7, 1771-1778.
267. Scopsi L., Migliari M., Vergani B. and Lombardi L. (1992) The use of fixed-frozen tissue in routine ultrastructural evaluation and immunogold labeling. Ultrastruct. Pathol. 16, 351-362.
268. Scott B. and Lew J. (1986) Neurons in cell culture survive freezing. Effect on electric membrane properties. Exper. Cell Res. 162, 566-573.
269. Shi J., Xiang Y. and Simpkins J. W. (1997) Hypoglycemia enhances the expression of mRNA encoding β-amyloid precursor protein in rat primary cortical astroglial cells. Brain Res. 772, 247-251.
270. Shichinohe S., Ozawa H., Saito T., Hashimoto E., Lang C., Riederer P. and Takahata N. (1998) Differential alteration of adenylyl cyclase subtypes I, II, and V/VI in postmortem human brains of heroin addicts. Alcohol. Clin. Exper. Res. 22, 84S-87S.
271. Shirakashi R. and Tanasawa I. (1998) Method of designing pre-freezing protocol in cryopreservation of biological materials. Ann. NY Acad. Sci. 858, 175-182.
272. Shyu A. B., Greenberg M. E. and Belasco J. G. (1989) The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Devel. 3, 60-72.
273. Siesjo B. K. (1981) Cell damage in the brain: a speculative synthesis. J. Cereb. Blood Flow Metab. 1, 155-185.
274. Sims N. R., Blass J. P., Murphy C., Bowen D. M. and Neary D. (1987) Phosphofructokinase activity in the brain in Alzheimer's disease. Ann. Neurol. 21, 509-510.
275. Skolnick P. (1999) Antidepressants for the new millennium. Eur. J. Pharmacol. 375, 31-40.
276. Sloviter R. S. and Connor J. D. (1977) Postmortem stability of norepinephrine, dopamine, and serotonin in rat brain. J. Neurochem. 28, 1129-1131.
277. Sokolov B. P. (1998) Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of 'neuroleptic-free' schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J. Neurochem. 71, 2454-2464.
278. Soreq H., Dziegielewska K. M., Zevin-Sonkin D. and Zakut H. (1986) The use of mRNA translation in vitro and in ovo followed by crossed immunoelectrophoretic autoradiography to study the biosynthesis of human cholinesterases. Cell. Molec. Neurobiol. 6, 227-237.
279. Soustek Z. (1989) Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralbl. Allg. Pathol. 135, 25-32.
280. Sowell E. R., Thompson P. M., Mattson S. N., Tessner K. D., Jernigan T. L., Riley E. P. and Toga A. W. (2002) Regional brain shape abnormalities persist into adolescence after heavy prenatal alcohol exposure. Cereb. Cortex 12, 856-865.
281. Sparks D. L., Beach T. G. and Lukas R. J. (1998) Immunohistochemical localization of nicotinic β2 and α4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations. Neurosci. Lett. 256, 151-154.
282. Spokes E. G. S. (1979) An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue. Brain 102, 333-346.
283. Spokes E. G. S. and Koch D. J. (1978) Post-mortem stability of dopamine, glutamate decarboxylase and choline acetyltransferase in the mouse brain under conditions simulating the handling of human autopsy material. J. Neurochem. 31, 381-383.
284. Spokes E. G. S., Garrett N. J. and Iversen L. L. (1979) Differential effects of agonal status on measurements of GABA and glutamate decarboxylase in human post-mortem brain tissue from control and Huntington's chorea subjects. J. Neurochem. 33, 773-778.
285. 123I]β-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and non-smokers. Synapse 41, 275-284.
286. Steward O., Torre E. R., Tomasulo R. and Lothman E. (1991) Neuronal activity up-regulates astroglial gene expression. Proc. Natl. Acad. Sci. USA 88, 6819-6823.
287. Stolle C. A. and Benz E. J. Jr (1988) Cellular factor affecting the stability of β-globin mRNA. Gene 62, 65-74.
288. Sullivan E. V., Lim K. O., Mathalon D. H., Marsh L., Beal D. M., Harris D., Hoff A. L., Faustman W. O. and Pfefferbaum A. (1998) A profile of cortical gray matter Volume deficits characteristic of schizophrenia. Cereb. Cortex 8, 117-124.
289. Swift G. H., Peyton M. J. and MacDonald R. J. (2002) Assessment of RNA quality by semi-quantitative RT-PCR of multiple regions of a long ubiquitous mRNA. Biotechniques 28, 524-526.
290. Symonds L. L., Archibald S. L., Grant I., Zisook S. and Jernigan T. L. (1999) Does an increase in sulcal or ventricular fluid predict where brain tissue is lost? J. Neuroimaging 9, 201-209.
291. Taghert P. H. (2001) How does the circadian clock send timing information to the brain? Semin. Cell. Dev. Biol. 12, 329-341.
292. Tanabe J. L., Amend D. L., Schuff N., DiSclafani V., Ezekiel F., Norman D., Fein G. and Weiner M. W. (1997) Tissue segmentation of the brain in Alzheimer disease. Am. J. Neuroradiol. 18, 115-123.
293. Tang Y. P., Shimizu E., Dube G. R., Rampon C., Kerchner G. A., Zhuo M., Liu G. and Tsien J. Z. (2001) Genetic enhancement of learning and memory in mice. Nature 401, 63-69.
294. Tanwar M. K., Gilbert M. R. and Holland E. C. (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res. 62, 4364-4368.
295. Toga A. W., Ambach K., Quinn B., Hutchin M. and Burton J. S. (1994) Postmortem anatomy from cryosectioned whole human brain. J. Neurosci. Meth 54, 239-252.
296. Tomlinson B. E. and Corsellis J. A. N. (1984) Ageing and the dementias. In: Greenfield's Neuropathology (Hume Adams J., Corsellis J. A. N. and Duchen L. W., eds), pp. 951-1025. John Wiley and Sons, New York.
297. Tong D., Schneeberger C., Leodolter S. and Zeillinger R. (1997) Quantitative determination of gene expression by competitive reverse transcription-polymerase chain reaction in degraded RNA samples. Anal. Biochem. 251, 173-177.
298. Tong J., Ross B. M., Sherwin A. L. and Kish S. J. (2001) Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain. Neurochem. Internat. 39, 117-125.
299. Ulrich J. and Stahelin H. B. (1984) The variable topography of Alzheimer type changes in senile dementia and normal old age. Gerontology 30, 210-214.
300. Verwer R. W., Hermens W. T., Dijkhuizen P., Ter Brake O., Baker R. E., Salehi A., Sluiter A. A., Kok M. J., Muller L. J., Verhaagen J. and Swaab D. F. (2002) Cells in human postmortem brain tissue slices remain alive for several weeks in culture. FASEB J. 16, 54-60.
301. Vitaterna M. H., King D. P., Chang A. M., Kornhauser J. M., Lowrey P. L., McDonald J. D., Dove W. F., Pinto L. H., Turek F. W. and Takahashi J. S. (1994) Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 264, 719-725.
302. Vitek M. P., Rasool C. G., de Sauvage F., Vitek S. M., Bartus R. T., Beer B., Ashton R. A., Macq A.-F., Maloteaux J.-M., Blume A. J. et al. (1988) Absence of mutation in the β-amyloid cDNAs cloned from the brains of three patients with sporadic Alzheimer's disease. Brain Res. 464, 121-131.
303. Vonsattel J. P., Aizawa H., Ge P., DiFiglia M., McKee A. C., MacDonald M., Gusella J. F., Landwehrmeyer G. B., Bird E. D., Richardson E. P. Jr et al. (1995) An improved approach to prepare human brains for research. J. Neuropathol. Exper. Neurol. 54, 42-56.
304. Wagey R., Pelech S. L., Duronio V. and Krieger C. (1998) Phosphatidylinositol 3-kinase: increased activity and protein level in amyotrophic lateral sclerosis. J. Neurochem. 71, 716-722.
305. Wakeman J. A., Heath P. R., Pearson R. C. and Andrews P. W. (1997) MAL mRNA is induced during the differentiation of human embryonal carcinoma cells into neurons and is also localised within specific regions of the human brain. Differentiation 62, 97-105.
306. Walder H. A. and Vrensen G. F. (1972) Effect of freezing and thawing on brain tissue of cats, studied by means of electron microscopy. Neurochirurgie 18, 142-150.
307. A receptor subunits in the human basal ganglia: An autoradiographic and immunohistochemical study. J. Comp. Neurol. 415, 313-340.
308. Wang Y., TesFaye E., Yasuda R. P., Mash D. C., Armstrong D. M. and Wolfe B. B. (2002) Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain. Molec. Brain Res. 80, 123-131.
309. Watkins K. E., Paus T., Lerch J. P., Zijdenbos A., Collins D. L., Neelin P., Taylor J., Worsley K. J. and Evans A. C. (2001) Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. Cereb. Cortex 11, 868-877.
310. Wender M., Adamczewska-Goncerzewicz Z. and Szczech J. (1994) Free sterols in senile human brain. Folia Neuropathol. 32, 75-79.
311. Wester P., Bateman D. E., Dodd P. R., Edwardson J. A., Hardy J. A., Kidd A. M., Perry R. H. and Singh G. B. (1985) Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain. Neurochem. Pathol. 3, 169-180.
312. Whitehouse P. J., Lynch D. R. and Kuhar M. J. (1984) Effects of post-mortem delay and temperature on transmitter receptor binding in a rat model of the human autopsy process. J. Neurochem. 43, 553-559.
313. Whitney L. W., Becker K. G., Tresser N. J., Caballero-Ramos C. I., Munson P. J., Prabhu V. V., Trent J. M., McFarland H. F. and Biddison W. E. (1999) Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 46, 425-428.
314. Wood T. L., Frantz G. D., Menkes J. H. and Tobin A. H. (1986) Regional distribution of messenger RNAs in postmortem human brain. J. Neurosci. Res. 16, 311-324.
315. Yasojima K., McGeer E. G. and McGeer P. L. (2001) High stability of mRNAs post-mortem and protocols for their assessment by RT-PCR. Brain Res. Prot. 8, 212-218.
316. Yates C. M., Butterworth J., Tennant M. C. and Gordon A. (1990) Enzyme activities in relation to pH and lactate in post-mortem brain in Alzheimer-type and other dementias. J. Neurochem. 55, 1624-1630.
317. Zhou C. J., Kikuyama S. and Shioda S. (2001a) Application and modification of in situ RT-PCR for detection and cellular localization of PAC1-R. splice variant mRnas in frozen brain sections. Biotechn Histochem. 76, 75-83.
318. Zhou J. N., Riemersma R. F., Unmehopa U. A., Hoogendijk W. J., van Heerikhuize J. J., Hofman M. A. and Swaab D. F. (2001b) Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch. General Psychiat. 58, 655-662.
319. Zubenko G. S., Stiffler J. S., Hughes H. B. and Martinez A. J. (1999) Reductions in brain phosphatidylinositol kinase activities in Alzheimer's disease. Biol. Psychiat. 45, 731-736.
320. Zubieta J. K., Dannals R. F. and Frost J. J. (1999) Gender and age influences on human brain μ-opioid receptor binding measured by PET. Am. J. Psychiat. 156, 842-848.
321. Zubieta J. K., Huguelet P., Ohl L. E., Koeppe R. A., Kilbourn M. R., Carr J. M., Giordani B. J. and Frey K. A. (2002) High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. Am. J. Psychiat. 157, 1619-1628.